Nantahala Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-150,000
Closed -$24.7M 124
2020
Q4
$24.7M Hold
150,000
0.76% 36
2020
Q3
$18.7M Hold
150,000
0.57% 39
2020
Q2
$14.6M Sell
150,000
-320,000
-68% -$33.3M 0.44% 48
2020
Q1
$42.2M Buy
470,000
+150,000
+47% +$19.4M 1.58% 16
2019
Q4
$47.3M Hold
320,000
1.46% 16
2019
Q3
$38.5M Hold
320,000
1.43% 22
2019
Q2
$43.3M Buy
320,000
+20,000
+7% +$2.53M 1.33% 23
2019
Q1
$39.1M Sell
300,000
-400,000
-57% -$53.7M 1.22% 21
2018
Q4
$87.1M Hold
700,000
2.68% 7
2018
Q3
$97.4M Buy
700,000
+500,000
+250% +$62.2M 2.62% 7
2018
Q2
$20.5M Hold
200,000
0.83% 34
2018
Q1
$19.4M Hold
200,000
0.87% 31
2017
Q4
$17.6M Buy
+200,000
New +$16.1M 0.78% 34

Other funds holding HCA

Nantahala Capital Management's HCA Position: Q2 2022 in Review

Nantahala Capital Management sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 35,600 shares — an estimated $8.92M sold.

Nantahala Capital Management first reported a position in HCA in Q1 2020 and held it in 9 quarters. The position peaked at $28.8M in Q2 2020. 884 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

  • Nantahala Capital Management reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
  • Nantahala Capital Management sold 35,600 HCA Healthcare shares in Q2 2022, an estimated $8.92M.
  • Nantahala Capital Management first reported a position in HCA Healthcare in Q1 2020 and held it in 9 quarters.
  • Nantahala Capital Management's HCA Healthcare position peaked at $28.8M in Q2 2020.
  • 884 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Nantahala Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.